18,19-Dinorpregn-4-en-20-yn-3-one,13-ethyl-17-hydroxy-11-methylene-, (17a)-
CAS : 54048-10-1
Ref. IN-DA00ILMQ
1g | Arrêté | ||
250mg | Arrêté |
Informations sur le produit
Nom :
18,19-Dinorpregn-4-en-20-yn-3-one,13-ethyl-17-hydroxy-11-methylene-, (17a)-
Synonymes :
- [u'13-ethyl-17-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one', u'3-keto-desogestrel', u'3-ketodesogestrel', u'3-oxo desogestrel', u'3-oxodesogestrel', u'etonogestrel', u'Implanon', u'nexplanon', u'ORG-3236', u'ETONOGESTREL', u'Implanon', u'54048-10-1', u'3-Oxodesogestrel', u'nexplanon', u'3-Ketodesogestrel', u'3-Keto-desogestrel', u'Org-3236', u'etonogestrelum', u'UNII-304GTH6RNH', u'ORG 3236', u'304GTH6RNH', u'CHEBI:50777', u'(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one', u'17-Ethinyl-17-beta-hydroxy-18-methyl-11-methylene-4-estren-3-one', u'EINECS 258-936-2', u'Implanon (TN)', u'13-Ethyl-17-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one', u'Etonogestrel (USAN/INN)', u'Etonogestrel [USAN:INN:BAN]', u'13-Ethyl-11-methylene-18,19-dinor-17-alpha-pregn-4-en-20-yn-3-one', u'(17-alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one', u'(17alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one', u'18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-, (17-alpha)-', u'NCGC00168777-01', u'3-Keto Desogestrel', u'AC1OCEK1', u'CHEMBL1531', u'DSSTox_CID_26782', u'DSSTox_RID_81900', u'DSSTox_GSID_46782', u'SCHEMBL117703', u'GTPL7590', u'DTXSID9046782', u'Etonogestrel (3-Ketodesogestrel)', u'Etonogestrel, >=98% (HPLC)', u'18,19-Dinor-17alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-', u'BCP28481', u'HY-B0652', u'3-Oxodesogestrel;3-keto-Desogestrel', u'Tox21_112638', u'BDBM50423516', u's4673', u'ZINC11680067', u'3-Ketodesogestrel|||3-Oxodesogestrel', u'17alpha-ethynyl-17beta-hydroxy-11-methylidene-18a-homo-estr-4-en-3-one', u'AKOS030526156', u'ACN-037292', u'CS-2884', u'DB00294', u'AN-40607', u'BC252319', u'CC-28331', u'CAS-54048-10-1', u'FT-0652914', u'D04104', u'048E101', u'C-23775', u'Etonogestrel, United States Pharmacopeia (USP) Reference Standard', u'(17|A)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one', u'Desogestrel Related Compound C, United States Pharmacopeia (USP) Reference Standard', u'(1S,2R,10S,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxy-17-methylidenetetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one', u'(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one', u'(8S,9S,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one', u'13-Ethyl-17-hydroxy-11-methylidene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one (3-Ketodesogestrel)', u'3-oxo desogestrel', u'NuvaRing (TN)', u'3-Keto-Org 2969', u'Etonogestrel [USAN:INN]', u'D02KIU', u'C22H28O2', u'C22-H28-O2', u'CID6917715', u'C044815', u'13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one', u'18,19-dinorpregn-4-en-20-in-3-ona, 13-etil-17-hidroxi-11-metileno-, (17?)-']
- (17-alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one
- (17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name)
- (17alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one
- (17Α)-13-Ethyl-17-Hydroxy-11-Methylene-18,19-Dinorpregn-4-En-20-Yn-3-One
- (17Α)-13-Ethyl-17-Hydroxy-11-Methylene-18,19-Dinorpregn-4-Ene-20-Yne-3-One
- (17Α)-13-Etil-17-Hidroxi-11-Metilen-18,19-Dinorpregn-4-En-20-In-3-Ona
- (17α)-13-Ethyl-17-hydroxy-11-methylen-18,19-dinorpregn-4-en-20-yn-3-on
- (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name)
- 13-Ethyl-11-methylene-18,19-dinor-17-alpha-pregn-4-en-20-yn-3-one
- Voir d'autres synonymes
- 13-Ethyl-17-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
- 17-Ethinyl-17-beta-hydroxy-18-methyl-11-methylene-4-estren-3-one
- 17-Ethynyl-17β-hydroxy-18-methyl-11-methyleneestr-4-en-3-one
- 18,19-Dinor-17alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-
- 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-, (17-alpha)-
- 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-, (17α)-
- 3-Keto-Org 2969
- 3-Keto-desogestrel
- 3-Ketodesogestrel
- 3-Oxodesogestrel
- Etonoestrel
- Etonogestrel [USAN:INN]
- Implanon
- Nexplanon
- Org 3236
- Unii-304Gth6Rnh
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Indagoo
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
324.4565
Formule :
C22H28O2
Degré de pureté :
98%
Couleur/Forme :
Solid
InChI :
InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1
Code InChI :
GCKFUYQCUCGESZ-BPIQYHPVSA-N
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :